Literature DB >> 8189525

Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.

J L Portis1, G J Spangrude, F J McAtee.   

Abstract

Neonatal inoculation of the wild-mouse ecotropic retrovirus CasBrE (clone 15-1) causes a noninflammatory spongiform neurodegenerative disease with an incubation period of > or = 6 months. Introduction of sequences from Friend murine leukemia virus (clone FB29) into the genome of CasBrE results in a marked shortening of the incubation period. The FB29 sequences which influence the incubation period were previously localized to the 5' leader sequence of the viral genome (M. Czub, F. J. McAtee, and J. L. Portis, J. Virol. 66:3298-3305, 1992). In the current study, we constructed a series of chimeric viruses consisting of the genome of CasBrE containing various segments of the leader sequence from FB29. A 41-nucleotide element (positions 481 through 521) near the 3' end of the leader was found to have a strong influence on the incubation period. This element influenced the kinetics of virus replication and/or spread in nonneuronal tissues, a property which was shown previously to determine the extent of central nervous system infection (M. Czub, F. J. McAtee, and J. L. Portis, J. Virol. 66:3298-3305, 1992). Curiously, this sequence had no demonstrable effect on virus replication in vitro in a fibroblastic cell line from Mus dunni. This segment encodes 14 of the unique 88-amino-acid N terminus of pr75gag, the precursor of a glycosylated form of the gag polyprotein which is expressed at the cell surface. Previous in vitro studies of mutants of Moloney murine leukemia virus lacking expression of glycosylated Gag failed to reveal a function for this protein in virus replication. We mutated the Kozak consensus sequence around the initiation codon for this protein in the chimeric virus CasFrKP, a virus which induces neurologic disease with a short (18- to 23-day) incubation period. M. dunni cells infected with the mutants lacked detectable cell surface Gag, but, compared with CasFrKP, no effect on replication kinetics in vitro was observed. In contrast, there was a marked slowing of the replication kinetics in vivo and a dramatic attenuation of neurovirulence. These studies indicate that glycosylated Gag has an important function in virus replication and/or spread in the mouse and further suggest that the sequence of its N terminus is a critical, though likely indirect, determinant of neurovirulence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189525      PMCID: PMC236893     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease.

Authors:  J L Portis; S Perryman; F J McAtee
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Complete nucleotide sequence of the neurotropic murine retrovirus CAS-BR-E.

Authors:  S M Perryman; F J McAtee; J L Portis
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

3.  Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons.

Authors:  D G Kay; C Gravel; Y Robitaille; P Jolicoeur
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane.

Authors:  E A Pillemer; D A Kooistra; O N Witte; I L Weissman
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential.

Authors:  Y Paquette; D G Kay; E Rassart; Y Robitaille; P Jolicoeur
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

6.  Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.

Authors:  J L Portis; S Czub; C F Garon; F J McAtee
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ectropic, amphotropic, xenotropic, and mink cell focus-forming viruses.

Authors:  M R Lander; S K Chattopadhyay
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus.

Authors:  L DesGroseillers; M Barrette; P Jolicoeur
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication.

Authors:  M Czub; S Czub; F J McAtee; J L Portis
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome.

Authors:  M Sitbon; B Sola; L Evans; J Nishio; S F Hayes; K Nathanson; C F Garon; B Chesebro
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

View more
  23 in total

1.  Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Authors:  M Hildinger; K L Abel; W Ostertag; C Baum
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles.

Authors:  R Fujisawa; F J McAtee; C Favara; S F Hayes; J L Portis
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Brain infection by neuroinvasive but avirulent murine oncornaviruses.

Authors:  S Asković; F J McAtee; C Favara; J L Portis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts.

Authors:  Takayuki Nitta; Yurii Kuznetsov; Alexander McPherson; Hung Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

Review 5.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

6.  Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6.

Authors:  M Kozak
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

7.  Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.

Authors:  R Fujisawa; F J McAtee; J H Zirbel; J L Portis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.

Authors:  S H Pincus; R Cole; R Ireland; F McAtee; R Fujisawa; J Portis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy.

Authors:  C Münk; J Löhler; V Prassolov; U Just; M Stockschläder; C Stocking
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

10.  The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag.

Authors:  R Fujisawa; F J McAtee; K Wehrly; J L Portis
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.